Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol

Andre Abitbol, May Abdel-Wahab, Alan Lewin, Michael Troner, Maria Amelia Rodrigues, Kara L. Hamilton-Nelson, Arnold Markoe

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol'. Together they form a unique fingerprint.

Medicine & Life Sciences

Physics & Astronomy